Navigation Links
Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
Date:11/5/2007

de Progen with confidence in the potential of PI-88 for this indication and we are therefore aggressively pursuing its development towards registration and commercialization.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.

This press release contains forward-looking statements that are based on current management expectations. These statements may differ materially from actual future events or results due to certain risks and uncertainties, including without limitation, risks associated with drug development and manufacture, risks inherent in the extensive regulatory approval process mandated by the United States Food and Drug Administration and the Australian Therapeutic Goods Administration, delays in obtaining the necessary approvals for clinical testing, patient recruitment, delays in the conduct of clinical trials, market acceptance of PI-88, PI-166 and other drugs, future capitals needs, general economic conditions, and other risks and uncertainties detailed from time to time in the Company's filings with the Australian Stock Exchange and the United States Securities and Exchange Commission. Moreover, there can be no assurance that others will not independently develop similar products or processes or design around patents owned or licensed by the Company, or that patents owned or licensed by the Company will provide meaningful protection or competitive advantages.


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
3. Progen Announces PI-88 Phase 2 Lung Cancer Results
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Calif. , Aug. 29, 2014 Medina ... as CEO and member of the Board of Directors ... of medical device development and commercialization experience, including over ... Mr. Engelson previously served as a Partner of the ... President and CEO of two Foundry start-ups. Mr. Engelson ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... , August 29, 2014 ... Seed Oil Market by Extraction type (SFE, Cold ... & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) ... by MarketsandMarkets, defines and segments the Amaranth Seed ... the market size in terms of value. The ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... Sept. 21, 2011 Reportlinker.com announces that a ... catalogue: Generic Drugs: The ... http://www.reportlinker.com/p0619264/Generic-Drugs-The-Global-Market-Focus-on-the-Americas.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment ... examination of the strategies employed by companies specializing ...
... SAN DIEGO, Sept. 20, 2011 Orexigen® Therapeutics, Inc. ... a recent meeting with senior officials in FDA,s Office ... detailing OND,s design requirements for a cardiovascular outcomes trial ... Letter (CRL) received in January 2011. Orexigen believes that ...
Cached Medicine Technology:Generic Drugs: The Global Market: Focus on the Americas 2Generic Drugs: The Global Market: Focus on the Americas 3Generic Drugs: The Global Market: Focus on the Americas 4Generic Drugs: The Global Market: Focus on the Americas 5Generic Drugs: The Global Market: Focus on the Americas 6Generic Drugs: The Global Market: Focus on the Americas 7Generic Drugs: The Global Market: Focus on the Americas 8Generic Drugs: The Global Market: Focus on the Americas 9Generic Drugs: The Global Market: Focus on the Americas 10Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 2Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 3Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 4Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 5
(Date:8/29/2014)... According to a CNN article, entitled Medical ... new study found that those states who legalized medical ... decrease in the number of painkiller overdoses seen. By ... and comparing various states with and without legalized medical ... about a 25% decrease in painkiller prescription overdoses in ...
(Date:8/29/2014)... 2014 As reported by the Frederick News Post ... Grad (8/17), a graduate of the Frederick County Drug Treatment ... own experience with the program. The graduate, Korey Shorb, put together ... 1 mile walk. He plans to donate the proceeds of the ... those who helped him. Shorb, who graduated in 2008, admitted that ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Healthpointe has ... will give patients the convenience of visiting with physicians ... doctors through telemedicine. , Healthpointe doctors are always available ... audio). If necessary, the doctor can even see the ... patient’s condition, he or she can prescribe medications that ...
(Date:8/29/2014)... News) -- Astronauts may be at heightened risk ... immune systems, a new study suggests. That could ... asteroids, the moon and Mars undertaken in the future, ... can be dangerous, NASA researchers say. They found ... of International Space Station crew members remains relatively unchanged ...
(Date:8/29/2014)... 2014 (HealthDay News) -- If you have bunions, taking care ... later, an expert says. A bunion is a bump ... bone or tissue moves out of place and extends beyond ... cause debilitating pain and may require surgery to correct, said ... Center in Freehold, N.J. To prevent bunions, avoid wearing ...
Breaking Medicine News(10 mins):Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:Drug Court Grad Brings More Life to Drug Court Program 2Health News:Drug Court Grad Brings More Life to Drug Court Program 3Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2Health News:Take Steps to Control Bunions 2
... Diluted Share, LARGO, Fla., May 28 ... Exchange: UVI), which develops,licenses, manufactures, distributes and markets ... the third quarter and first nine,months of FY2008., ... quarter ended March 31,2008 increased to $1,668,397 compared ...
... 2008 - You went to a wedding yesterday. The service ... dancing all night. But people tell you that you are ... and that you didnt go to a wedding yesterday at ... following neurological damage is known as confabulation. The reasons why ...
... new vegetarian food that boosts the uptake of iron and ... the result of a doctoral dissertation by Charlotte Eklund-Jonsson at ... Sweden. , The food, called tempe, is moreover a whole-grain ... in medicine that whole-grains reduce the risk of cardiovascular diseases, ...
... Hainan, China, May 28 /Xinhua-PRNewswire-FirstCall/ --,China Pharma ... Bulletin,Board: CPHI) which develops, manufactures, and markets ... announced that it has entered,into a Securities ... institutional and accredited investors ("Investors") pursuant to ...
... access to insurance tend to have healthier children , , WEDNESDAY, ... care in America varies widely from state to state, ... likelihood of living long and healthy lives. , That,s the ... a private foundation that seeks to promote better health care ...
... advantage of quick and,easy travel to the beautiful ... Conference: Leadership Development - Finding, Growing & Retaining,Top ... ), sponsored by Best Practices,LLC,s GLOBAL BENCHMARKING ... Fla., Registration ends this week so sign ...
Cached Medicine News:Health News:Unilens Vision Reports Increased Royalty Income 2Health News:Unilens Vision Reports Increased Royalty Income 3Health News:Unilens Vision Reports Increased Royalty Income 4Health News:China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million 2Health News:China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million 3Health News:States' Scorecard Finds Big Differences in Kids' Health Care 2Health News:States' Scorecard Finds Big Differences in Kids' Health Care 3Health News:Registration Ends This Week: Fortune 500 Networking & Best Practice Sharing Conference in Florida 2
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: